COLE DIAGNOSTICS

What COLE DIAGNOSTICS does

Cole Diagnostics is an independent, full-service clinical reference laboratory headquartered in Garden City, Idaho, operating a single processing facility that handles blood work, molecular diagnostics, cytology, and biopsy diagnosis. Founded in 2004 and led by Dr. Ryan Cole, the laboratory is staffed by board-certified pathologists, molecular scientists, microbiologists, cytotechnologists, histotechnologists, and Med Techs, and serves two primary customer segments: healthcare providers (physicians, clinics, and hospitals that order tests) and individual patients who access collection services directly. Its technical platform centers on automated and advanced chemistry analyzers and molecular diagnostic workflows, supported by CLIA certification (ID 13D251000).

The company's revenue model is fee-for-service laboratory testing, billed primarily through insurance as an in-network provider with nine major payers (Medicare, Idaho Medicaid, United, Humana, Aetna, Cigna, Tricare, Blue Cross of Idaho, and Regence Blue Shield), supplemented by self-pay pricing anchored to the Medicare allowable fee schedule and an online PayPal bill-pay portal. Patient-facing specimen collection is delivered through ExpressLab-branded patient service centers, separating the collection channel from central processing. Differentiators emphasized in the company's own materials are definitive and transparent pathology reporting, a no-automated-phone policy with live staff answering, and a high-touch service posture positioned against large corporate reference laboratories. Geographic reach is Idaho-only with no disclosed expansion or capital-raise activity.

Name

COLE DIAGNOSTICS

Legal name

Cole Diagnostics

Website

https://colediagnostics.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

Cole Diagnostics is an independent clinical reference laboratory in Garden City, Idaho, providing pathology, blood work, molecular diagnostics, cytology, and biopsy diagnosis to healthcare providers and patients, with specimen collection delivered through ExpressLab-branded patient service centers.

Ownership category

akta.pro rank

Product category

Medical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Hematology & Coagulation Laboratories (HLAFAMAC)

Keywords

• Medical laboratory testing
• Pathology diagnostic services
• Clinical laboratory analysis
• Molecular diagnostic testing
• Biopsy diagnosis services

Headquarters

HQ city

Garden City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Revenue model

1. Laboratory Testing Services: Cole Diagnostics generates revenue through providing medical laboratory testing services including blood work, molecular testing, cytology, and biopsy diagnosis. Revenue is collected through insurance billing (as an in-network provider for many plans), direct patient payment at time of service, and patient billing for amounts not covered by insurance.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Cole Diagnostics operates an independent, full-service reference medical laboratory providing pathology and clinical laboratory diagnostic services, including blood work, molecular diagnostics, cytology, and biopsy diagnosis. Specimens are processed at its main CLIA-certified laboratory facility in Boise, Idaho, with patient specimen collection offered through patient service centers operating under the ExpressLab brand.

Product overview

Cole Diagnostics operates as an independent medical laboratory offering a unified portfolio of diagnostic services. The core offering consists of comprehensive medical laboratory diagnostic services including pathology, clinical laboratory testing, blood work, molecular testing, cytology, and biopsy diagnosis. These services are supported by patient billing services for online payment processing. The laboratory is led by Dr. Ryan Cole and staffed with physicians, molecular scientists, microbiologists, cytotechnologists, histotechnologists, and Med Techs. The company emphasizes accurate diagnostics, innovative technology with automated and advanced chemistry analyzers, and high-touch customer service with no automated phone answering.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Laboratory Diagnostic Services Comprehensive medical laboratory diagnostic services including pathology, clinical laboratory testing, blood work, molecular diagnostics, cytology, and biopsy diagnosis provided to healthcare providers and patients by board-certified pathologists and laboratory scientists.
• ExpressLab Patient Service Centers Direct specimen collection services for individual patients, operated under the ExpressLab brand, enabling walk-in access to blood draws and other specimen collection for laboratory testing processed by Cole Diagnostics.

Named customers9 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• ExpressLabcoreChannel Partner/ Reseller/ DistributorPatient service centers are now operating under the ExpressLab brand, suggesting a distribution or operational partnership where ExpressLab handles patient-facing specimen collection while Cole Diagnostics processes tests at their main laboratory facility.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Clinical Pathology Laboratories (CPL): CPL is a regional clinical reference laboratory providing routine and specialty testing across the southern and central United States with patient service centers. Comparable to Cole on the regional independent reference lab model, in-network payer strategy, and routine plus specialty test mix.
• Laboratory Corporation of America (Labcorp): Labcorp is one of the two largest US clinical reference laboratories with national patient service centers and a broad routine/specialty test menu. Cole competes with Labcorp head-to-head for in-network commercial and Medicare physician referrals in Idaho.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is a major US reference laboratory offering highly specialized and routine clinical testing for hospitals, clinics, and physicians across the country. Comparable to Cole on the reference-lab business model and on esoteric test capabilities including molecular and anatomic pathology.
• ARUP Laboratories: ARUP is a nonprofit, academic-affiliated reference laboratory specializing in esoteric and routine clinical testing for hospitals and health systems nationwide. Cole's esoteric/molecular/especialty pathology positioning makes ARUP a relevant peer on test menu and physician-serve model.
• NeoGenomics: NeoGenomics is a US specialty oncology reference laboratory focused on hematopathology, solid tumor molecular profiling, and cytogenetic testing for community oncologists. Comparable to Cole on the anatomic pathology and molecular diagnostics portion of the test menu, particularly the biopsy and cytology lines.
• BioReference Laboratories: BioReference is a US clinical reference laboratory offering routine diagnostics, women's health, oncology, and molecular/urology testing to physicians and patients. Comparable to Cole on anatomic pathology, molecular diagnostics, and physician-driven test menu.
• PathGroup: PathGroup is one of the largest US private pathology-focused reference laboratories serving hospitals, health systems, and physician offices across the Southeast and beyond. Like Cole, it is a physician-led, regionally rooted anatomic pathology and clinical lab peer with similar scale relative to national players.
• Quest Diagnostics: Quest Diagnostics is the largest US clinical reference laboratory offering routine and specialty testing, anatomic pathology, and employer health services. It is Cole's most direct national competitor, competing for the same physician referral and payer relationships across routine chemistry, molecular, and cytology work.

Broad incumbents

• Sonic Healthcare: Sonic Healthcare is a global medical diagnostics operator with reference laboratory, pathology, and radiology services across multiple geographies. It is a broad incumbent peer to Cole rather than a direct head-to-head in Idaho, but is comparable on reference lab services, anatomic pathology, and hospital outreach.

Emerging players

• Guardant Health: Guardant Health is a precision oncology company offering liquid biopsy and molecular profiling tests to oncologists and biopharma. It does not directly compete with Cole on routine clinical lab volume, but overlaps on the molecular diagnostics and biopsy-derived testing portions of Cole's menu.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/colediagnostics
• Xx.com/ColeDiagnostics
• LinkedInlinkedin.com/company/cole-diagnostics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about COLE DIAGNOSTICS